Spotlight on Surgery

Credits: 1.00 CME
Enhanced Recovery Protocols in Ileus Prevention: An Analysis of Real-Life Cases
Timothy Beard, MD, FACS
Postgraduate Institute for Medicine

Enhanced Recovery Protocols in Ileus Prevention: An Analysis of Real-Life Cases

Start
Free CME
1.0 AMA PRA Category 1 Credit(s)
Released: December 28, 2018
Expires: December 28, 2019
1 hour to complete

Jointly Provided By

Postgraduate Institute for Medicine and Miller Medical Communications, LLC.

Statement of Commercial Support

This activity is supported by an independent educational grant from Merck & Co., Inc.

Target Audience

This activity is intended for health care professionals engaged in the care of patients undergoing surgery.

Learning Objectives

Upon completion of this activity, the learners will be better able to:

  • Analyze the burden of postoperative ileus from a clinical and economic perspective
  • Analyze pharmacological and nonpharmacological approaches to prevent postoperative ileus
  • Evaluate and discuss surgical case scenarios of postoperative ileus prevention and treatment

Activity Description

In a roundtable discussion, 3 surgeons from different specialties (colorectal, urologic, and general surgery) present numerous real-life cases illustrating how ERAS protocols and proactive strategies to prevent postoperative ileus have influenced patient outcomes and hospital length of stay. The dynamic process of adoption of ERAS protocols in their respective institutions serves as a real-life template to avoid pitfalls and to optimize patient safety and recovery.

Faculty

Timothy L. Beard, MD, FACS
Chair
Department of Surgery
Summit Medical Group Oregon–Bend Medical Memorial Clinic
Bend, Oregon


Marc A. Singer, MD, FACS, FASCRS
Associate Professor of Surgery
Division of Colon and Rectal Surgery
Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois


Edouard J. Trabulsi, MD, FACS
Professor and Vice Chair
Department of Urology
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, Pennsylvania


Conflict of Interest Policy/Disclosure Statement

The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty
Timothy L. Beard, MD, FACS: Consulting Fees (e.g. advisory boards): Merck
Marc A. Singer, MD, FACS, FASCRS: Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their agents (e.g., speakers’ bureaus): Merck, Nestle, Applied Medical, Ethicon, Olympus; Ownership Interestgreater than 5% (stocks, stock options, or other ownership interest excluding diversified mutual funds): Chicago Colorectal Symposium
Edouard J. Trabulsi, MD, FACS: Has nothing to disclose

The PIM planners and managers have nothing to disclose. The Miller Medical Communications, LLC. planners and managers have nothing to disclose.

Joint Accreditation Statement

Accreditation Council for Pharmacy EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Miller Medical Communications, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

There are no fees for participating in and receiving CME/CE credit for this activity. During the period December 28, 2018, through December 28, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

Kerri Leonard, Kerri.Leonard@millermeded.com, 212-661-7400, ext. 9
Jennifer Kunst, jkunst@pimed.com, 720-895-5333

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Surgery Presentations

1.00 CME
Postgraduate Institute for Medicine
Enhanced Recovery Protocols in Ileus Prevention: An Analysis of Real-Life Cases

Enhanced Recovery Protocols in Ileus Prevention: An Analysis of Real-Life Cases

Start
Free CME
1.0 AMA PRA Category 1 Credit(s)
Released: December 28, 2018
Expires: December 28, 2019
1 hour to complete

Jointly Provided By

Postgraduate Institute for Medicine and Miller Medical Communications, LLC.

Statement of Commercial Support

This activity is supported by an independent educational grant from Merck & Co., Inc.

Target Audience

This activity is intended for health care professionals engaged in the care of patients undergoing surgery.

Learning Objectives

Upon completion of this activity, the learners will be better able to:

  • Analyze the burden of postoperative ileus from a clinical and economic perspective
  • Analyze pharmacological and nonpharmacological approaches to prevent postoperative ileus
  • Evaluate and discuss surgical case scenarios of postoperative ileus prevention and treatment

Activity Description

In a roundtable discussion, 3 surgeons from different specialties (colorectal, urologic, and general surgery) present numerous real-life cases illustrating how ERAS protocols and proactive strategies to prevent postoperative ileus have influenced patient outcomes and hospital length of stay. The dynamic process of adoption of ERAS protocols in their respective institutions serves as a real-life template to avoid pitfalls and to optimize patient safety and recovery.

Faculty

Timothy L. Beard, MD, FACS
Chair
Department of Surgery
Summit Medical Group Oregon–Bend Medical Memorial Clinic
Bend, Oregon


Marc A. Singer, MD, FACS, FASCRS
Associate Professor of Surgery
Division of Colon and Rectal Surgery
Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois


Edouard J. Trabulsi, MD, FACS
Professor and Vice Chair
Department of Urology
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, Pennsylvania


Conflict of Interest Policy/Disclosure Statement

The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty
Timothy L. Beard, MD, FACS: Consulting Fees (e.g. advisory boards): Merck
Marc A. Singer, MD, FACS, FASCRS: Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their agents (e.g., speakers’ bureaus): Merck, Nestle, Applied Medical, Ethicon, Olympus; Ownership Interestgreater than 5% (stocks, stock options, or other ownership interest excluding diversified mutual funds): Chicago Colorectal Symposium
Edouard J. Trabulsi, MD, FACS: Has nothing to disclose

The PIM planners and managers have nothing to disclose. The Miller Medical Communications, LLC. planners and managers have nothing to disclose.

Joint Accreditation Statement

Accreditation Council for Pharmacy EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Miller Medical Communications, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

There are no fees for participating in and receiving CME/CE credit for this activity. During the period December 28, 2018, through December 28, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

Kerri Leonard, Kerri.Leonard@millermeded.com, 212-661-7400, ext. 9
Jennifer Kunst, jkunst@pimed.com, 720-895-5333

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.